Prize Papers 9: AMD III

This session will take place on 10th September at 13:00 CEST.

Chairperson(s): S. Vujosevic ITALY

Speakers:

Presentations:

Chairperson

13:00 Welcome and introduction

R. Gale UK

13:01 Long-term efficacy outcomes with Brolucizumab vs Aflibercept treatment in patients with early residual fluid presence in nAMD: post hoc analysis of pooled data from HAWK & HARRIER studies

J. Ehlers USA

13:05 The safety-specific, next-generation optical coherence tomography analysis from HAWK: preliminary qualitative OCT findings associated with intraocular inflammation

All Faculty

13:09 Discussion

S. Wolf SWITZERLAND

13:15 Association between visual acuity and intraretinal or subretinal fluid in patients with neovascular age-related macular degeneration treated with intravitreal aflibercept treat-and-extend: A post hoc analysis of the ARIES study

M. Gillies AUSTRALIA

13:19 Shorter treatment intervals are associated with higher treatment compliance than longer treatment intervals in a treat-and-extend regimen for nAMD

All Faculty

13:23 Discussion

R. MacLaren UK

13:29 Preliminary results from a first-in-human Phase I/II gene therapy study (FOCUS) of GT005, an investigational AAV2 vector encoding complement factor I, in patients with geographic atrophy

C. Jamison UK

13:33 Idiopathic serous epithelial detachments (SPEDs) and choroidal thickness in UK Biobank (UKBB)

All Faculty

13:37 Discussion

13:45 End of Session